Detalhe da pesquisa
1.
Planning for post-pandemic cancer care delivery: Recovery or opportunity for redesign?
CA Cancer J Clin
; 71(1): 34-46, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32997807
2.
PROMISE Registry: A prostate cancer registry of outcomes and germline mutations for improved survival and treatment effectiveness.
Prostate
; 84(3): 292-302, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964482
3.
Postradical prostatectomy prostate-specific antigen outcomes after 6 versus 18 months of perioperative androgen-deprivation therapy in men with localized, unfavorable intermediate-risk or high-risk prostate cancer: Results of part 2 of a randomized phase 2 trial.
Cancer
; 130(9): 1629-1641, 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38161319
4.
Comparison of outcomes for Hispanic and non-Hispanic patients with advanced renal cell carcinoma in the International Metastatic Renal Cell Carcinoma Database.
Cancer
; 2024 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297953
5.
The impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.
Cancer
; 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38376917
6.
A Pooled Analysis of 3 Phase II Trials of Salvage Nivolumab/Ipilimumab After Nivolumab in Renal Cell Carcinoma.
Oncologist
; 29(4): 324-331, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37950901
7.
Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas.
Mod Pathol
; 37(2): 100404, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38104891
8.
PADRES: a phase 2 clinical trial of neoadjuvant axitinib for complex partial nephrectomy.
BJU Int
; 133(4): 425-431, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37916303
9.
Prostate Cancer, Version 3.2024.
J Natl Compr Canc Netw
; 22(3): 140-150, 2024 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38626801
10.
Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol.
Future Oncol
; 20(12): 727-738, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38488039
11.
A plain language summary exploring a new treatment combination for untreated locally advanced or metastatic urothelial cancer: enfortumab vedotin plus pembrolizumab.
Future Oncol
; 20(7): 351-360, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37994649
12.
Optimizing outcomes in men with prostate cancer: the cardiovascular event lowering (CaELo) pathways.
Can J Urol
; 31(2): 11820-11825, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38642459
13.
Differential responses to taxanes and PARP inhibitors in ATM- versus BRCA2-mutated metastatic castrate-resistant prostate cancer.
Prostate
; 83(3): 227-236, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36382533
14.
Comprehensive genomic profiling of penile squamous cell carcinoma and the impact of human papillomavirus status on immune-checkpoint inhibitor-related biomarkers.
Cancer
; 129(24): 3884-3893, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37565840
15.
Visceral Metastasis Predicts Response to New Hormonal Agents in Metastatic Castration-Sensitive Prostate Cancer.
Oncologist
; 28(7): 596-603, 2023 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37084289
16.
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy.
Oncologist
; 2023 Jun 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-37368355
17.
Prostate Cancer, Version 4.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(10): 1067-1096, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37856213
18.
Treatment Landscape of Renal Cell Carcinoma.
Curr Treat Options Oncol
; 24(12): 1889-1916, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153686
19.
Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US.
Qual Life Res
; 32(11): 3209-3221, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410340
20.
New drug approvals in prostate cancer and their effect on the treatment landscape.
Clin Adv Hematol Oncol
; 21(6): 321-340, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530638